CBD and Chronic Pain: Where It Helps and Where It Does Not
The Distinction That Changes the Answer
Most of the encouraging research on cannabis and chronic pain did not test CBD on its own. It tested cannabis containing THC, or a combination of THC and CBD together. That distinction is routinely lost in marketing, and it is the single most important thing to understand here.
When trials have looked at CBD alone for chronic pain, results have been modest, mixed, or no better than placebo. When trials have looked at THC-containing preparations — particularly for neuropathic pain and for spasticity in multiple sclerosis — the picture is stronger, though still short of what most people assume.
What the Serious Reviews Concluded
Major pain bodies have looked at this evidence and declined to endorse cannabinoids as a general treatment for chronic pain, citing insufficient high-quality trial data. That is not a dismissal of the field; it is a statement about how much we actually know.
Where the evidence is comparatively better is narrow and specific: neuropathic pain — nerve pain, the burning or electric kind — and spasticity. Both are conditions where THC plays a substantial role in the preparations that were studied.
Why CBD Alone May Still Do Something
This is worth stating fairly. CBD has genuine anti-inflammatory activity in laboratory and animal studies, and there are plausible mechanisms by which it could affect pain perception. Many people report that it helps them.
But "plausible mechanism plus positive reports" is where most supplements sit. It is a reason to keep studying and a reasonable basis for a supervised trial in an individual. It is not the same as demonstrated efficacy, and anyone telling you otherwise is selling something.
The Practical Problem in Costa Rica Right Now
There is a specific local complication. The evidence that looks best for pain involves THC — and at the moment the only cannabis products registered for sale in Costa Rica are dried flower. No oil, capsule, or measured-dose THC preparation is registered yet.
So the honest position is this: CBD is what is readily available, and its evidence for chronic pain is weaker than its reputation. That is a reason for realistic expectations, not a reason to do nothing.
What a Reasonable Approach Looks Like
If you are considering CBD for chronic pain, three things make the attempt worthwhile rather than wishful.
Measure something. Pick one outcome before you start — hours slept, steps walked, a pain score at the same time each day. "It feels a bit better" cannot be evaluated after six weeks.
Use an adequate dose for an adequate time. A few drops for a week has not tested anything. Our guide to CBD dosing sets out how to do this properly.
Do it with a physician if you take other medication. Chronic pain patients are frequently on drugs that CBD interacts with, including some blood thinners and anti-seizure medications. See CBD drug interactions.
What Would Change This Article
Larger trials of CBD alone, and the arrival of registered measured-dose THC products in Costa Rican pharmacies. Both are plausible within a few years. Until then, the honest summary is that cannabis has a real place in pain management, and CBD by itself is the least-proven part of it.